Our findings raise an interesting question regarding the potential significance of ZMIZ1 effects on AR mediated transcription in prostate cancer pathogenesis and particularly in disease progression during androgen deprivation therapy. The gene discussed is ZMIZ1; the disease is prostate carcinoma.